FDA clears 1st AI sepsis monitoring tool

Giles Bruce / beckershospitalreview - A tool from tech company Bayesian Health has become the first continuous AI sepsis monitor to gain FDA approval. The solution monitors hospital patients to detect deterioration and flag sepsis early on. The application was developed at Baltimore-based Joh…

AI Summary: Regulators have cleared the first AI‑driven sepsis early‑warning system for clinical deployment, enabling hospitals to use algorithmic alerts to identify patients at risk of deterioration earlier. The clearance opens the door for broader adoption of AI in acute care while renewing debates about clinical oversight, false alarms and integration into existing workflows.

#healthcare #publichealth #fda #digitalhealth #medicaldevices #hospitaloperations #infectiousdisease #healthit

7 wks / nature

1 month / medicalxpress


Back to Top / Sat, May 16, 2026, 1:21 am / permalink 23878 / 7 stories in 1 month /




Related Stories


Studies warn AI chatbots give dangerously confident, misleading medical advice / 2 months

AI flags thousands more at risk of sudden cardiac death than standard methods / 14 days

IRhythm discloses cybersecurity incident, launches investigation / 21 days

WellSpan and Philips ink seven-year AI imaging partnership / 5 wks

Postoperative 1,000‑step target lowers readmissions and speeds recovery / 2 months

DeepRare AI beats clinicians at diagnosing rare diseases / 4 months

EHR‑based marker flags transplant patients at risk of rejection / 21 days

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Clinical Trials, CDC, Oncology, Alzheimer's disease and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.